5:45 PM
 | 
Oct 16, 2012
 |  BC Extra  |  Company News

Ironwood sets linaclotide price

Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) set the wholesale acquisition cost (WAC) of newly approved gastrointestinal drug Linzess linaclotide at $7.10 per day, or about $2,591 per year. Ironwood said it and partner...

Read the full 142 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >